Upgrade to SI Premium - Free Trial

Zimmer Biomet (ZBH) PT Raised to $116 at UBS

May 3, 2023 4:13 AM
UBS analyst Danielle Antalffy raised the price target on Zimmer Biomet (NYSE: ZBH) to $116.00 (from $112.00) while maintaining a Sell rating.

Categories

Analyst PT Change

Next Articles